Towards an understanding of psychedelic-induced neuroplasticity

Towards an understanding of psychedelic-induced neuroplasticity

Classic psychedelics, such as LSD, psilocybin, and the DMT-containing beverage ayahuasca, show some potential to treat depression, anxiety, and addiction. Importantly, clinical improvements can last for months or years after treatment. It has been theorized that these long-term improvements arise because psychedelics rapidly and lastingly stimulate neuroplasticity. The focus of this review is on answering specific questions about the effects of …

Psychedelics May 'Reset' Brain Cells in Mood And Immune Disorders

Scientists at Harvard University are proposing a fundamental change in the way we consider psychedelics and their therapeutic potential.

Could psychedelics help you to drink less alcohol? Our new study aims to find out

Master1305/ShutterstockPsychedelics like LSD and psilocybin (the active ingredient in magic mushrooms) are gaining increasing attention in psychiatry. Studies suggest they may offer therapeutic benefits for conditions such as depression, anxiety, obsessive–compulsive disorder, eating disorders and addiction. Our research team is investigating whether N,N-dimethyltryptamine (DMT), a fast-acting psychedelic, can help people reduce alcohol consumpt…

Psychedelic Therapy Can Help Reduce Problematic Alcohol And Tobacco Use, Scientific Review Shows

A new scientific review on psychedelics as a possible treatment for substance use disorders finds that psilocybin-assisted psychotherapy “showed significant reductions in alcohol consumption and high smoking cessation rates” and has potential to lessen opioid dependence. Psilocybin-assisted therapy (PAP) “was associated with significant reductions in alcohol consumption, smoking cessation, and related psychological improvements,” says the resear…

Psilocybin May Treat Symptoms of Bipolar II Depression Without Triggering Mania or Psychosis, Says Study

The Marijuana Herald - Marijuana news and information A study published recently from researchers at the University of Toronto and McMaster University finds that psilocybin, a psychedelic compound found in magic mushrooms, may safely reduce symptoms of depression in patients with Bipolar II disorder without triggering mania or psychosis. Dried psilocybin. Published in the journal Psychedelic Medicine and epulbished by the U.S. National Library o…

Cannabis study: legalization reduces problematic consumption - particularly among certain individuals